LongeVC managing partner Sergey Jakimov joined The Biotech Startups Podcast for an in-depth four-part conversation with Jon Chee, where he talked about his path from post soviet Latvia to longevity investing and how it shaped his approach.
The conversation also explored how approaching problems without preconceived limitations can unlock unconventional solutions, why pharma's patent cliffs create opportunities for venture-backed innovation, and LongeVC's mission to establish longevity as a data-driven, evidence-based field while combating questionable therapies in the market.
You can listen to the podcast here: Part 1, Part 2, Part 3, Part 4
The conversation also explored how approaching problems without preconceived limitations can unlock unconventional solutions, why pharma's patent cliffs create opportunities for venture-backed innovation, and LongeVC's mission to establish longevity as a data-driven, evidence-based field while combating questionable therapies in the market.
You can listen to the podcast here: Part 1, Part 2, Part 3, Part 4